Answer
Tezepelumab targets thymic stromal lymphopoietin (TSLP), preventing its interaction with the TSLP receptor.
Sources for this answer
- Tezspire 210 mg solution for injection in pre-filled syringeAstraZeneca UK Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 4Document updated
Sources checked